GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (OTCPK:ACIXF) » Definitions » Float Percentage Of Total Shares Outstanding

ACIXF (Acarix AB) Float Percentage Of Total Shares Outstanding : 0.00% (As of Dec. 14, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Acarix AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Acarix AB's float shares is 0.00 Mil. Acarix AB's total shares outstanding is 1,063.74 Mil. Acarix AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Acarix AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Acarix AB's Institutional Ownership is 0.01%.

Acarix AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Acarix AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,063.74
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acarix AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (OTCPK:ACIXF) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:ARCOMA OSTO:SCIB OSTO:ICO XSAT:PHI XSAT:VSD B NGM:MCLR OSTO:SDOS XSAT:REDS XSAT:CSMED OSTO:NEOLA ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
ACARIX:Sweden 7AC:Germany
Address
World Trade Center Malmo, Jungmansgatan 12, Malmo, SWE, 211 19
Website
https://www.acarix.com
Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96 percent certainty.